Could a new drug replace steroids for brain tumor swelling?
NCT ID NCT07694089
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This trial compares three approaches to manage brain swelling after surgery for high-grade glioma: standard steroids (dexamethasone), no routine steroids, and a study drug called azeliragon that targets swelling through a different mechanism. The goal is to see if these alternatives can control swelling with fewer side effects. About 80 adults with newly diagnosed glioma will be randomly assigned to one of the three groups and followed for two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexamethasone and Azeliragon
- What this could lead to
- If successful, this could offer safer ways to manage brain swelling after tumor surgery, reducing steroid-related side effects.
- What could go wrong
- This is a small, early-phase trial. The alternatives may not control swelling as well as steroids, or could have unknown risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-GRADE GLIOMAS (HGG) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
UofL Health Brown Cancer Center; University of Louisville Hospital
Louisville, Kentucky, 40202, United States
Contact Phone: •••-•••-••••
-
UofL Health Jewish Hospital
Louisville, Kentucky, 40202, United States